Cargando…
Natural Progression of Left Ventricular Function following Anthracyclines without Cardioprotective Therapy: A Systematic Review and Meta-Analysis
SIMPLE SUMMARY: Anthracyclines form the backbone of many systemic chemotherapy regimens with great response rates for cancers. Yet, their established dose-limiting cardiotoxic effects can also lead to a reduction in cardiac function and an increased risk of heart failure. This PRISMA-adherent system...
Autores principales: | Lee, Ainsley Ryan Yan Bin, Yau, Chun En, Low, Chen Ee, Li, Jiaqi, Tyebally, Sara Moiz, Lin, Weiqin, Tan, Li-Ling, Liao, Chia-Te, Chang, Wei-Ting, Lee, Matilda Xinwei, Koo, Chieh-Yang, Sia, Ching-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856944/ https://www.ncbi.nlm.nih.gov/pubmed/36672461 http://dx.doi.org/10.3390/cancers15020512 |
Ejemplares similares
-
Severity and Longitudinal Course of Depression, Anxiety and Post-Traumatic Stress in Paediatric and Young Adult Cancer Patients: A Systematic Review and Meta-Analysis
por: Lee, Ainsley Ryan Yan Bin, et al.
Publicado: (2023) -
Inter-Individual Variation and Cardioprotection in Anthracycline-Induced Heart Failure
por: Norton, Nadine, et al.
Publicado: (2021) -
New Insight Into Cardioprotection From Anthracyclines: Still Converging on the Mitochondria
por: Chen, Qun, et al.
Publicado: (2023) -
Global Longitudinal Strain Monitoring to Guide Cardioprotective Medications During Anthracycline Treatment
por: Marwick, Thomas H.
Publicado: (2022) -
Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer
por: Henriksen, Peter A., et al.
Publicado: (2023)